source
- Eli Lilly's 340B claims data deadline passes, sparking potential new disputeEli Lilly set a deadline for hospitals to submit 340B drug‑pricing program claims data under its new policy. The deadline has now passed, and the company has not indicated what actions it will tak…
- Merck, Gilead report mixed outcomes in key lung cancer, HIV studiesTrodelvy's latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV tablet could boost Gilead's main business.